|
rs10489265
|
|
|
0.010 |
GeneticVariation |
BEFREE |
To replicate the association, two single-nucleotide polymorphisms (SNPs: rs2205960 and rs10489265) were genotyped in 814 SLE patients.
|
23936824 |
2013 |
|
rs7574865
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Furthermore, the stratified meta-analysis also demonstrate that the STAT4 rs7574865 polymorphism is associated with the presence of autoantibodies with systemic reactivity (anti-ds-DNA antibodies) in SLE patients (OR = 1.37; 95% CI = 1.21 - 1.56, P = 1.12 × 10(-6)).
|
23628400 |
2013 |
|
rs17266594
|
|
|
0.010 |
GeneticVariation |
BEFREE |
This study implies that rs10516487 and rs17266594 polymorphisms might contribute to individual susceptibility to SLE and influence the ANA/SSA autoantibody response in SLE patients in Chinese population.
|
21078628 |
2011 |
|
rs2910164
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The G and C allele frequencies of rs2</span>910164 were 39 and 61% in SLE patients, but 36 and 64% in healthy group (P = 0.990), respectively.
|
20845080 |
2011 |
|
rs3746444
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The C and T allele frequencies of rs3746444 were 15 and 85% in SLE patients, but 14 and 86% in healthy group (P = 0.702), respectively.
|
20845080 |
2011 |
|
rs2069705
|
|
|
0.010 |
GeneticVariation |
BEFREE |
SLE susceptibility association was significant with rs2069705 in the promoter (adjusted OR 2.27, p=0.0024) and marginal with rs3181032 in the promoter (p=0.037), rs2430561 in intron 1 (p=0.022) and rs2069718 in intron 3 (p=0.026) in a recessive genetic model.
|
19919944 |
2010 |
|
rs2069718
|
|
|
0.010 |
GeneticVariation |
BEFREE |
SLE susceptibility association was significant with rs2069705 in the promoter (adjusted OR 2.27, p=0.0024) and marginal with rs3181032 in the promoter (p=0.037), rs2430561 in intron 1 (p=0.022) and rs2069718 in intron 3 (p=0.026) in a recessive genetic model.
|
19919944 |
2010 |
|
rs2430561
|
|
|
0.010 |
GeneticVariation |
BEFREE |
SLE susceptibility association was significant with rs2069705 in the promoter (adjusted OR 2.27, p=0.0024) and marginal with rs3181032 in the promoter (p=0.037), rs2430561 in intron 1 (p=0.022) and rs2069718 in intron 3 (p=0.026) in a recessive genetic model.
|
19919944 |
2010 |
|
rs3181032
|
|
|
0.010 |
GeneticVariation |
BEFREE |
SLE susceptibility association was significant with rs2069705 in the promoter (adjusted OR 2.27, p=0.0024) and marginal with rs3181032 in the promoter (p=0.037), rs2430561 in intron 1 (p=0.022) and rs2069718 in intron 3 (p=0.026) in a recessive genetic model.
|
19919944 |
2010 |
|
rs1799983
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Glu298Asp eNOS polymorphism is not associated with SLE.
|
19318399 |
2009 |
|
rs549908
|
|
|
0.010 |
GeneticVariation |
BEFREE |
IL-18 105 A>C polymorphism contributes to renal manifestations in patients with SLE.
|
19387647 |
2009 |
|
rs1061622
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Lack of association between the Met196Arg polymorphism in the TNFR2 gene and autoimmune diseases accompanied by vasculitis including SLE in Japanese.
|
11169260 |
2001 |